title: Long-term use of anagrelide in the treatment of children with essential thrombocythemia.
authors.forename: Herwig
authors.initials: H
authors.lastname: Lackner
authors.forename: Christian
authors.initials: C
authors.lastname: Urban
authors.forename: Martin
authors.initials: M
authors.lastname: Benesch
authors.forename: Andrea
authors.initials: A
authors.lastname: Moser
authors.forename: Petra
authors.initials: P
authors.lastname: Sovinz
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Schwinger
authors.forename: Hans Jürgen
authors.initials: HJ
authors.lastname: Dornbusch
mesh_terms: D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D013920:Thrombocythemia, Essential / Q000188:drug therapy*
chemical_list: D010975:Platelet Aggregation Inhibitors; D011799:Quinazolines; C021139:anagrelide